                         SEQUENCE LISTING

<110>  MaRS Innovation
 
<120>  SPECIFIC ACTIVE SITE INHIBITORS OF ENZYMES AND METHODS OF 
       PRODUCING SAME

<130>  31840/46164

<150>  61/372,133
<151>  2010-08-10

<160>  173   

<170>  PatentIn version 3.5

<210>  1
<211>  76
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin wildtype

<400>  1

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  2
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 8.2

<400>  2

Met Arg Ile Val Val Lys Thr Leu Met Gly Arg Thr Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Asn His 
    50                  55                  60                  


Ser Ala Leu Tyr Leu Leu Leu Lys Leu Arg Gly Gly 
65                  70                  75      


<210>  3
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 8.3

<400>  3

Met Tyr Ile Phe Val Lys Thr Phe Met Gly Arg Thr Ile Tyr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Ser Lys Val 
    50                  55                  60                  


Ser Ala Leu Tyr Leu Leu Phe Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  4
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 21.1

<400>  4

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Ile 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Met Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  5
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 21.2

<400>  5

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Lys Arg 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Lys Leu Arg Gly Gly 
65                  70                  75      


<210>  6
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 21.3

<400>  6

Met Gln Ile Phe Val Lys Thr Gly Thr Gly Lys Thr Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Lys Ser 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  7
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 21.4

<400>  7

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Trp 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  8
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant 21.5

<400>  8

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Gly Gly 
65                  70                  75      


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Asp Tyr Lys Asp Asp Asp Lys 
1               5           


<210>  10
<211>  69
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  pdl1

<220>
<221>  misc_feature
<222>  (16)..(18)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (22)..(24)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (28)..(30)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (34)..(48)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (52)..(54)
<223>  n is a, c, g, or t

<400>  10
gacgatgaca aaatgnnnat tnnngtgnnn accnnnnnnn nnnnnnnnat cnnnctcgag       60

gttgaaccc                                                               69


<210>  11
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  pdl2

<220>
<221>  misc_feature
<222>  (16)..(18)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (22)..(24)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (28)..(33)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (37)..(39)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (43)..(45)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (49)..(60)
<223>  n is a, c, g, or t

<400>  11
atccaggata aggaannnat tnnncctnnn nnncagnnnc tgnnntttnn nnnnnnnnnn       60

ctggaagatg gacgt                                                        75


<210>  12
<211>  63
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  pdl3

<220>
<221>  misc_feature
<222>  (16)..(24)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (28)..(30)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (34)..(36)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (40)..(48)
<223>  n is a, c, g, or t

<400>  12
tctgactaca atattnnnnn nnnntctnnn cttnnncttn nnnnnnnnct tcgtggtggt       60

ggc                                                                     63


<210>  13
<211>  227
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 8.2

<400>  13
atgcggattg tcgtgaaaac ccttatgggg aggaccatca cctcgaggtt gaaccctcgg       60

atacgataga aaatgtaaag gccaagatcc aggataagga aggaattcct cctgatcagc      120

agagactgat ctttgctggc aagcagctgg aagatggacg tactttgtct gactacaata      180

ttcacaatca ctctgctctt tatcttttgt tgaaacttcg tggtggt                    227


<210>  14
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 8.3

<400>  14
atgtatattt tcgtgaaaac cttcatgggg aggaccatct acctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

atttcaaagg tgtctgctct ttaccttctg ttcagacttc gtggtggt                   228


<210>  15
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 21.1

<400>  15
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attcagaaga tttctactct ttttcttctt atgagacttc gtggtggt                   228


<210>  16
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 21.2

<400>  16
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attctgaagc ggtctactct ttttcttctc ttgaaacttc gtggtggt                   228


<210>  17
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 21.3

<400>  17
atgcaaattt tcgtgaaaac cggtacgggg aagaccatca ttctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attcttaagt cgtctacgct ttttcttttg ttgagacttc gtggtggt                   228


<210>  18
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 21.4

<400>  18
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attcaaaagt ggtctacgct ttttcttttg ttgagacttc gtggtggt                   228


<210>  19
<211>  228
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic nucleotide


<220>
<221>  misc_feature
<223>  Ubiquitin variant 21.5

<400>  19
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attcagaagg actctactct ttttcttctg ttgaggcttc gtggtggt                   228


<210>  20
<211>  228
<212>  DNA
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  Ubiquitin wildtype

<400>  20
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg       60

gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag      120

cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat      180

attcaaaagg agtctactct tcatcttgtg ttgagacttc gtggtggt                   228


<210>  21
<211>  78
<212>  PRT
<213>  Homo sapiens

<400>  21

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  22
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP2-A1

<400>  22

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Met Arg Leu Trp Ser His Arg Arg 
65                  70                  75              


<210>  23
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP2-A10

<400>  23

Met Gln Ile Phe Val Asn Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Trp Ser Glu Gly Thr 
65                  70                  75              


<210>  24
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP2-A12

<400>  24

Met Gln Ile Phe Val Met Thr Leu Thr Gly Gln Asn Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Gly Gly His 
65                  70                  75              


<210>  25
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-A3

<400>  25

Met Gln Ile Phe Val Lys Thr Leu Trp Thr Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Tyr Gly Val Lys Arg 
65                  70                  75              


<210>  26
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-A6

<400>  26

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Tyr Gly Gln Ala Ala 
65                  70                  75              


<210>  27
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-A7

<400>  27

Met Asp Ile Phe Val Asn Thr Ile Thr Gly Lys Ile Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Arg Tyr 
    50                  55                  60                  


Ser Thr Leu His Leu Leu Leu Arg Leu Arg Gly Glu Ile Gln 
65                  70                  75              


<210>  28
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-A9

<400>  28

Met Gln Ile Phe Val Met Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Tyr 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Gly Val Ser His 
65                  70                  75              


<210>  29
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-B10

<400>  29

Met Gln Ile Phe Val Tyr Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Tyr Ser Leu Asp Arg 
65                  70                  75              


<210>  30
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-B11

<400>  30

Met His Ile Phe Val Asn Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Trp Ser Cys Lys Gly 
65                  70                  75              


<210>  31
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-B12

<400>  31

Met Gln Ile Phe Val Lys Thr Leu Ser Gly Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Gly Arg Lys 
65                  70                  75              


<210>  32
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-B7

<400>  32

Met Gln Ile Phe Val Asn Thr Leu Thr Gly Thr His Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  33
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-B8

<400>  33

Met Gln Ile Phe Val Met Thr Leu Thr Gly Lys His Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  34
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C10

<400>  34

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu His Ser Asn Ala Met 
65                  70                  75              


<210>  35
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C11

<400>  35

Met Gln Ile Phe Val Lys Thr Ile Ala Gly Lys Ala Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Gly Lys Arg 
65                  70                  75              


<210>  36
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C3

<400>  36

Met Gln Ile Phe Val Asn Thr Leu Ser Gly Lys His Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  37
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C5

<400>  37

Met Gln Ile Phe Val Asn Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Phe Ser Ala Arg Val 
65                  70                  75              


<210>  38
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C7

<400>  38

Met Gln Ile Phe Val Asn Thr Leu Thr Gly Arg His Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  39
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C8

<400>  39

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Gly Arg Arg 
65                  70                  75              


<210>  40
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-C9

<400>  40

Met Gln Ile Phe Val Asn Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Trp Ser Trp Arg Arg 
65                  70                  75              


<210>  41
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D1

<400>  41

Met Gln Ile Phe Val Asn Thr Leu Thr Ala Arg Asn Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Leu Arg Ser Glu Asn Leu 
65                  70                  75              


<210>  42
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D11

<400>  42

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Gly Ser Ile 
65                  70                  75              


<210>  43
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D3

<400>  43

Met Asp Ile Phe Val Asn Thr Leu Thr Gly Asn Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  44
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D4

<400>  44

Met Glu Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Trp Ser Ile Ser Phe 
65                  70                  75              


<210>  45
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D6

<400>  45

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Ser Arg Ser Lys 
65                  70                  75              


<210>  46
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D7

<400>  46

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Leu Gly Tyr Ser Lys 
65                  70                  75              


<210>  47
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  USP2-D9

<400>  47

Met Asn Ile Phe Val Lys Thr Leu Ala Gly Asn His Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  48
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-E4

<400>  48

Met Glu Ile Tyr Val Asn Thr Arg Leu Leu Glu Thr Ile Asn Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Lys 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Leu Arg Leu Leu Gly Gln Arg His 
65                  70                  75              


<210>  49
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-F11

<400>  49

Met Gln Ile Phe Val Gln Thr Arg Val Met Asn Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Thr Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Asp 
    50                  55                  60                  


Ser Thr Leu His Leu Leu Leu Arg Met Arg Arg Leu Asn Lys 
65                  70                  75              


<210>  50
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-F3

<400>  50

Met Gln Ile Phe Val Gln Thr Arg Ala Met Trp Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  51
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-F7

<400>  51

Met Gln Ile Phe Val Asn Thr Arg Thr Met Phe Thr Ile Arg Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  52
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-F8

<400>  52

Met Arg Ile Phe Val Lys Thr Arg Met Met Glu Ser Ile Phe Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Gln 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Val Arg Phe Arg Ser Ala Arg Arg 
65                  70                  75              


<210>  53
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-F9

<400>  53

Met Pro Ile Phe Val Asn Thr Arg Trp Met Lys Thr Ile Pro Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Asp Arg Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Asp Leu Gly Val Phe Cys 
65                  70                  75              


<210>  54
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G10

<400>  54

Met Gln Ile Met Val His Thr Arg Val Met Asn Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  55
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G11

<400>  55

Met Gln Ile Ser Val Asn Thr Arg Met Met Glu Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Pro Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  56
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G3

<400>  56

Met Gln Ile Val Val Asn Thr Arg Met Met Glu Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  57
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G4

<400>  57

Met His Ile Phe Val Asn Thr Arg Ile Met Glu Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  58
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G5

<400>  58

Met His Ile Ser Val Asn Thr Arg Ser Met Trp Thr Ile Gln Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  59
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G6

<400>  59

Met Gln Ile Phe Val His Thr Arg Met Met Glu Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  60
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G8

<400>  60

Met Gln Ile Ile Val Arg Thr Arg Ala Met Trp Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Arg Thr Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  61
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-G9

<400>  61

Met Gln Ile Phe Val Asn Thr Arg Met Met Asp Ser Ile Met Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  62
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H10

<400>  62

Met Gln Ile Phe Val Asn Thr Arg Met Met Met Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  63
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H11

<400>  63

Met Gln Ile Val Val Asn Thr Arg Ser Met Asn Thr Ile His Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Arg 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  64
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H12

<400>  64

Met Arg Ile Val Val Asn Thr Arg Tyr Met Asn Thr Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Thr Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  65
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H4

<400>  65

Met Gln Ile Phe Val Asn Thr Arg Leu Met Tyr Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Ile Ser Arg Gly Leu Pro 
65                  70                  75              


<210>  66
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H7

<400>  66

Met Gln Ile Leu Val Arg Thr Arg Ile Met Glu Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Asn 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  67
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H8

<400>  67

Met Gln Ile Phe Val Asn Thr Arg Met Met Glu Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ser Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Arg Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Ser 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  68
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP5-H9

<400>  68

Met Gln Ile Phe Val Asn Thr Arg Met Met Asn Thr Ile Asp Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  69
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP10-Ubv.10.1

<400>  69

Met Gln Ile Phe Val Glu Thr Pro Met Gly Lys Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Val Phe Val Gly Lys 
        35                  40                  45              


Leu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Arg Trp 
    50                  55                  60                  


Ser Thr Leu Ala Leu Lys Phe Arg Leu Leu Ala Lys Asn Leu 
65                  70                  75              


<210>  70
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP48-Ubv.48.01

<400>  70

Met Gln Ile Ile Val Lys Thr Leu Thr Gly Gly Thr Ile Gly Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Trp Thr 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Met Glu 
    50                  55                  60                  


Ser Thr Leu Arg Leu Phe Leu Arg Pro Arg Gly Leu Lys Glu 
65                  70                  75              


<210>  71
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP48-Ubv.48.02

<400>  71

Met Gln Ile Ser Val Lys Thr Leu Thr Gly Asn Met Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Thr Phe Val Phe Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gly Lys His 
    50                  55                  60                  


Ser Thr Leu His Leu Trp Leu Arg Leu Leu Gly Ile Gly Lys 
65                  70                  75              


<210>  72
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP48-Ubv.48.03

<400>  72

Met Gln Ile Phe Val Lys Thr Leu Asn Gly Asn Ile Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Trp Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu Pro Leu Phe Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  73
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP48-Ubv.48.04

<400>  73

Met Gln Ile Ser Val Lys Thr Leu Thr Gly Gly Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Phe Thr 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gly Lys Gln 
    50                  55                  60                  


Ser Thr Leu His Leu Trp Leu Arg Leu Leu Gly Leu Glu Glu 
65                  70                  75              


<210>  74
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP48-Ubv.48.05

<400>  74

Met Arg Ile Phe Val Glu Thr Leu Thr Gly Gln Ile Ile Asn Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Asn Phe Ala Gly Lys 
        35                  40                  45              


Leu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Trp 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  75
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-A11

<400>  75

Met Leu Ile Leu Val Lys Thr Leu Thr Gly His Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Phe 
    50                  55                  60                  


Ser Thr Leu His Leu Val Lys Arg Leu Arg Gly Arg Trp Lys 
65                  70                  75              


<210>  76
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-A9

<400>  76

Met Arg Ile Phe Val Thr Thr Leu Thr Gly Arg Ala Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Thr Gly Lys 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Lys Arg Leu Arg Gly Met Glu Gln 
65                  70                  75              


<210>  77
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-B1

<400>  77

Met His Ile Phe Val Arg Thr Leu Thr Arg Lys Ile Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Thr Gly Met 
        35                  40                  45              


Thr Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  78
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-B10

<400>  78

Met Arg Ile Leu Val Lys Thr Leu Thr Arg Lys Val Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Gln 
        35                  40                  45              


Arg Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  79
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-B4

<400>  79

Met Gln Ile Phe Val Lys Thr Met Arg Arg Glu Ser Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Thr Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Lys Arg Leu Pro Gly Arg Gln Tyr 
65                  70                  75              


<210>  80
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-B5

<400>  80

Met Gln Ile Val Val Lys Thr Leu Ser Arg Arg Thr Ile Gly Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Ala Leu Lys Leu Pro Gly Met Gly Gly 
65                  70                  75              


<210>  81
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-B6

<400>  81

Met Gln Ile Phe Val Lys Thr Phe Thr Gly Lys Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Asp Arg Asn 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Glu 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  82
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C1

<400>  82

Met Gln Ile Leu Val Gln Thr Leu Thr Arg Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Gly Thr 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys His 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Leu Arg Leu Leu Gly Arg Arg His 
65                  70                  75              


<210>  83
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C10

<400>  83

Met Gln Ile Leu Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Leu 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Val 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Lys Thr Phe Pro Gly Arg Arg Gln 
65                  70                  75              


<210>  84
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C11

<400>  84

Met Gln Ile Phe Val Lys Thr Leu Ala Gly Trp Gly Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Arg Tyr Asp 
    50                  55                  60                  


Ser Thr Leu His Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  85
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C12

<400>  85

Met Gln Ile Leu Val Lys Thr Leu Ala Arg Thr Ser Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  86
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C2

<400>  86

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu His Leu Val Arg Arg Leu Pro Arg Met Gly Lys 
65                  70                  75              


<210>  87
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C4

<400>  87

Met Tyr Ile Ser Val Lys Thr Leu Thr Gly Glu Ser Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Phe Phe Ala Gly Lys 
        35                  40                  45              


Ile Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Lys Trp 
    50                  55                  60                  


Ser Thr Leu His Leu Val Lys Arg Leu Arg Ala Val His Met 
65                  70                  75              


<210>  88
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C5

<400>  88

Met Gln Ile Phe Val Lys Thr Leu Thr Arg Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Arg Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  89
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-C6

<400>  89

Met Pro Ile Val Val Lys Thr Leu Ala Gly Tyr Thr Ile His Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Leu Phe Ala Gly Asn 
        35                  40                  45              


Arg Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Asn Gly 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Lys Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  90
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D1

<400>  90

Met Gln Ile Phe Val Asn Thr Leu Ala Arg Thr Ser Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Pro Gly Thr Lys Val 
65                  70                  75              


<210>  91
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D10

<400>  91

Met Gln Ile Phe Val Arg Thr Leu Met Arg Lys Ser Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Leu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Lys Lys Leu Ile Leu Leu Arg Glu 
65                  70                  75              


<210>  92
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D11

<400>  92

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  93
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D12

<400>  93

Met Gln Ile Tyr Val Lys Thr Leu Thr Arg Lys Arg Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Phe Phe Asn Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  94
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D2

<400>  94

Met Gln Ile Tyr Val Lys Thr Leu Thr Arg Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Val Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  95
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D3

<400>  95

Met Lys Ile Ser Val Asn Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Tyr 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Lys Arg Leu Arg Arg Leu Lys Gln 
65                  70                  75              


<210>  96
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D5

<400>  96

Met Gln Ile Phe Val Pro Thr Leu Val Gln Lys Ala Ile Asn Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Phe Arg Lys 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Leu Trp Arg Phe Ser Ser Arg Leu Met 
65                  70                  75              


<210>  97
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D8

<400>  97

Met Gln Ile Phe Val Arg Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Lys Gln 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Lys Glu 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Arg Arg Leu Arg Gly Leu Val Ser 
65                  70                  75              


<210>  98
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Nedd4-N4-D9

<400>  98

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Gln Val 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Lys Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  99
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.01

<220>
<221>  MISC_FEATURE
<223>  Ubv.ITCH.0

<400>  99

Met Pro Ile Leu Val Lys Thr Leu Arg Gly Gln Ser Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Phe Leu Ile Phe Ala Arg Lys 
        35                  40                  45              


His Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Arg 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Phe Leu Arg Phe His Gly Met Val Ala 
65                  70                  75              


<210>  100
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.02

<400>  100

Met His Ile Leu Val Lys Thr Leu Arg Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Leu Phe Gly Gly Asn 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Leu Arg Arg Leu Gly Ser Lys Phe 
65                  70                  75              


<210>  101
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.03

<400>  101

Met Gln Ile Phe Val Ile Thr His Thr Trp Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Leu Phe Ala Arg Gln 
        35                  40                  45              


Lys Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Ile Arg Arg Val Ser Lys Arg 
65                  70                  75              


<210>  102
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.04

<400>  102

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Leu Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ile Leu Ile Phe Gly Gly Lys 
        35                  40                  45              


Arg Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Lys 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Met Arg Leu Arg Gly Val Ser Arg 
65                  70                  75              


<210>  103
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.05

<400>  103

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Thr Asp Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ile Leu Leu Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Gly Asp 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Met Arg Phe Gly Val Asn Lys Arg 
65                  70                  75              


<210>  104
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.ITCH.06

<400>  104

Met Pro Ile Leu Val Gln Thr Leu Arg Gly Gln Ser Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Phe Leu Ile Phe Ala Arg Thr 
        35                  40                  45              


His Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Gly 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Leu Arg Phe His Gly Thr Val Ala 
65                  70                  75              


<210>  105
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1.01

<400>  105

Met Gln Ile Leu Val Lys Thr Val Ile Val Lys Thr Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Thr Leu Ile Phe Ala Gly Met 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Arg Arg Ala 
    50                  55                  60                  


Ser Thr Leu His Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  106
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1.02

<400>  106

Met Gln Ile Phe Val Gln Thr Leu Ile Val Lys Thr Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Tyr Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gly Met Glu 
    50                  55                  60                  


Ser Thr Leu Arg Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  107
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1.03

<400>  107

Met Pro Ile Ser Val Val Thr Leu Ile Val Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ser Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Asn Arg 
    50                  55                  60                  


Ser Thr Leu His Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  108
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1.04

<400>  108

Met Leu Ile Phe Val Thr Thr Val Arg Val Ser Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Leu Lys Glu 
    50                  55                  60                  


Ser Thr Leu Lys Leu Val Trp Ile Phe Arg Gly Asn Arg Thr 
65                  70                  75              


<210>  109
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.01

<400>  109

Met Gln Ile Leu Val Lys Thr Val Ile Val Lys Thr Ile Ser Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Thr Leu Ile Phe Ala Gly Met 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Arg Arg Ala 
    50                  55                  60                  


Ser Thr Leu His Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  110
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.02

<400>  110

Met Glu Ile Val Val Gln Thr Leu Ile Val Lys Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Gly Gly Asp 
        35                  40                  45              


Phe Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Ser Trp Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  111
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.03

<400>  111

Met Gln Ile Ile Val Glu Thr Ile Thr Val Lys Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu Leu Leu Val Ser Trp Leu His Gly Asp Arg Gln 
65                  70                  75              


<210>  112
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.04

<400>  112

Met Gln Ile Phe Val Gln Thr Leu Ile Val Lys Thr Ile Ile Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Tyr Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gly Met Glu 
    50                  55                  60                  


Ser Thr Leu Arg Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  113
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.05

<400>  113

Met Gln Ile Phe Val Gln Thr Ile Thr Val Met Arg Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Met 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Arg Asp 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Ser Ser Leu Arg Gly Leu Arg Ala 
65                  70                  75              


<210>  114
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1a.06

<400>  114

Met Gln Ile Phe Val Gln Thr Leu Thr Val Lys Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Arg 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Gly 
    50                  55                  60                  


Ser Thr Leu His Leu Val Ala Trp Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  115
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.01

<400>  115

Met Arg Ile Phe Val Lys Thr Ile Thr Val Lys Ser Ile His Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Thr Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Leu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Ala Lys His Arg Gly Met Glu Val 
65                  70                  75              


<210>  116
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.02

<400>  116

Met Gln Ile Phe Val Lys Thr Leu Thr Val Thr Thr Ile Tyr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Leu Lys Phe Arg Ala Leu Val Arg 
65                  70                  75              


<210>  117
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.03

<400>  117

Met Gln Ile Phe Val Ile Thr Phe Ser Gly Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Asn Leu Ile Phe Gly Gly Arg 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Gln Val 
    50                  55                  60                  


Ser Thr Leu Leu Leu Val Leu Ser Leu Arg Gly Thr Arg Glu 
65                  70                  75              


<210>  118
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.04

<400>  118

Met Gln Ile Phe Val Lys Thr Leu Ala Val Lys Thr Ile Glu Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Leu Ser Val Arg Val Leu Arg Arg 
65                  70                  75              


<210>  119
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.05

<400>  119

Met Gln Ile Asn Val Asn Thr Leu Met Val Lys Ala Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Gly Ala Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Phe Ser Leu Arg Gly Lys Gly Gln 
65                  70                  75              


<210>  120
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.06

<400>  120

Met Leu Ile Phe Val Lys Thr Leu Arg Val Glu Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gly Lys Glu 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Thr Arg Leu Arg Val Tyr Glu Ser 
65                  70                  75              


<210>  121
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.07

<400>  121

Met Thr Ile Phe Val Thr Thr Ile Ile Val Asn Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Lys Lys Glu 
    50                  55                  60                  


Ser Thr Leu Arg Leu Val Ser Arg His Arg Arg Thr Val Lys 
65                  70                  75              


<210>  122
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.08

<400>  122

Met His Ile Phe Val Lys Thr Leu Thr Val Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Val Arg Gln 
        35                  40                  45              


His Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Leu Ser Leu Arg Gly Ile Ala Lys 
65                  70                  75              


<210>  123
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.09

<400>  123

Met Gln Ile Phe Val Gly Thr Leu Thr Val Asn Gly Ile Asn Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Val Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  124
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.10

<400>  124

Met Gln Ile Phe Val Lys Thr Leu Thr Val Asn Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Ser Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  125
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.11

<400>  125

Met Gln Ile Leu Val Thr Thr Ile Ile Val Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ser Gly Lys 
        35                  40                  45              


Glu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Arg Asn Lys 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Val Gly Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  126
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.12

<400>  126

Met Gln Ile Phe Val Asn Thr Leu Arg Ala Lys Phe Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Leu Phe Ala Gly Gln 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu Ser Leu Val Ala Ser Leu Arg Gly Asp Gln Lys 
65                  70                  75              


<210>  127
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.13

<400>  127

Met Gln Ile Phe Val Leu Thr Leu Lys Trp Lys Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ser Gly Trp 
        35                  40                  45              


His Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Glu Lys Gly 
    50                  55                  60                  


Ser Thr Leu Gly Leu Val Leu Thr Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  128
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.14

<400>  128

Met Glu Ile Ser Val Lys Thr Leu Ala Val Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Ala Gly Lys 
        35                  40                  45              


Leu Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Arg Glu 
    50                  55                  60                  


Ser Thr Leu Leu Leu Val Leu Arg Ile Tyr Arg Arg Ala Ser 
65                  70                  75              


<210>  129
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant Ubv.UIM1b.15

<400>  129

Met Lys Ile Phe Val Thr Thr Leu Thr Val Lys Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Gly Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Leu Leu Gly Val Met Leu Arg Ala Asn Arg Ser 
65                  70                  75              


<210>  130
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A01

<400>  130

Met Gln Ile Phe Val Lys Thr Pro Lys Gly Lys Asn Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ile Ala Lys 
        35                  40                  45              


His Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu Ser Leu Leu Met Ser Phe Pro Arg Thr Val Arg 
65                  70                  75              


<210>  131
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A03

<400>  131

Met Gln Ile Phe Val Lys Thr Leu Arg Gly His Leu Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Val Ala Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu Gln Leu Met Phe Lys Pro Arg Gly Gln Arg Arg 
65                  70                  75              


<210>  132
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A04

<400>  132

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ser Leu Ser Phe Ala Gly Lys 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Arg Thr 
    50                  55                  60                  


Ser Thr Leu His Leu Val Phe Ser Phe Arg Ser Arg Val Lys 
65                  70                  75              


<210>  133
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A06

<400>  133

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Ser Leu Ser Phe Ala Gly Lys 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Arg Thr 
    50                  55                  60                  


Ser Thr Leu His Leu Val Phe Ser Phe Arg Ser Lys Val Lys 
65                  70                  75              


<210>  134
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A07

<400>  134

Met Gln Ile Phe Val Lys Thr Leu Arg Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Phe Phe Asp Val Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Glu 
    50                  55                  60                  


Ser Thr Leu Asp Leu Phe Leu Gly Leu Arg Gly Arg Ser Arg 
65                  70                  75              


<210>  135
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A08

<400>  135

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ser Gly Lys 
        35                  40                  45              


Pro Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu Asp Leu Gly Leu Arg Arg Arg Thr Thr Val Ser 
65                  70                  75              


<210>  136
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-A09

<400>  136

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Asn Trp Glu 
    50                  55                  60                  


Ser Thr Leu Arg Leu Trp Ser Arg Val Arg Gly Lys Tyr Gln 
65                  70                  75              


<210>  137
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-B03

<400>  137

Met Gln Ile Phe Val Lys Thr Val Lys Gly Glu Thr Ile Val Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Lys Leu Tyr Phe Asp Val Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Gln Glu 
    50                  55                  60                  


Ser Thr Leu His Leu Leu Val Arg Leu Gly Gly Arg Gly Gly 
65                  70                  75              


<210>  138
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-B06

<400>  138

Met Gln Ile Phe Val Ile Thr Phe Pro Gly Lys Thr Ile Ala Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Leu Phe Asp Val Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Asn Glu 
    50                  55                  60                  


Ser Thr Leu Asn Leu Val Trp Arg Pro Arg Gly Val Leu Asn 
65                  70                  75              


<210>  139
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-B09

<400>  139

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Asp Val Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Thr Tyr 
    50                  55                  60                  


Ser Thr Leu His Leu Gly Leu Arg Leu Arg Gly His Thr Thr 
65                  70                  75              


<210>  140
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP8-B10

<400>  140

Met Gln Ile Phe Val Lys Thr Leu Met Gly Arg Ala Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Ala 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Met Leu Arg Leu Arg Gly Gly Gly Gly 
65                  70                  75              


<210>  141
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  141

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Glu Trp Lys 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Ser Ile Leu Leu 
65                  70                  75              


<210>  142
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  142

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Val Arg Leu Phe Val Lys Gln Ile 
65                  70                  75              


<210>  143
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  143

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Glu Thr Gly 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Phe Arg Leu Arg Gly Met Gly Thr 
65                  70                  75              


<210>  144
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  144

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Leu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Phe Arg Ser Tyr Met Arg 
65                  70                  75              


<210>  145
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  145

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Tyr His Lys 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Val Lys Phe Arg Gly Leu Thr Pro 
65                  70                  75              


<210>  146
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  146

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Asn Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Phe Pro Arg Val Gln Ala 
65                  70                  75              


<210>  147
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  147

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Lys Ala 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu His Ala Gln Arg Arg 
65                  70                  75              


<210>  148
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  148

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Phe 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Gly Gly Trp Tyr Leu 
65                  70                  75              


<210>  149
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  149

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Gln 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Leu Arg Gly Lys Asp Met 
65                  70                  75              


<210>  150
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  150

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Arg Gln 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Ile Arg Ile His Arg Arg Lys Arg 
65                  70                  75              


<210>  151
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  151

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys His 
    50                  55                  60                  


Ser Thr Leu Tyr Leu Leu Phe Arg Phe Thr Val Lys Gly Arg 
65                  70                  75              


<210>  152
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  152

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Pro Arg His 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Phe Arg Leu Arg Asp Thr Ser Arg 
65                  70                  75              


<210>  153
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  153

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Ala 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Val Arg Ala His Lys Gln 
65                  70                  75              


<210>  154
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  154

Met Glu Ile Phe Val Lys Thr Leu Ser Gly Met Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys His 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Leu His Val Gly Asn Asn 
65                  70                  75              


<210>  155
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  155

Met Gln Ile Phe Val Lys Thr Val Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Lys 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Leu His Ser Thr Arg Glu 
65                  70                  75              


<210>  156
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  156

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Phe Arg Gly Thr Leu Ser 
65                  70                  75              


<210>  157
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  157

Met Gln Ile Phe Val Lys Thr Val Thr Gly Arg Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Thr Lys 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Phe Arg Gly Asn Thr Arg 
65                  70                  75              


<210>  158
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  158

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Glu Lys Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Pro Ser Trp Lys Gly 
65                  70                  75              


<210>  159
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  159

Met Gln Ile Tyr Val Lys Thr Leu Pro Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Leu Arg 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Phe Arg Pro Arg Arg Leu Tyr Lys 
65                  70                  75              


<210>  160
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  160

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Glu Lys Lys 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Tyr Trp Glu Asp Lys 
65                  70                  75              


<210>  161
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  161

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Tyr Asn Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Ala Arg Leu Arg Phe Gly Arg Ala 
65                  70                  75              


<210>  162
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  162

Met Gln Ile Phe Val Lys Thr Ser Thr Gly Arg Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Arg Gln 
    50                  55                  60                  


Ser Thr Leu Phe Leu Ile Trp Arg Leu Thr Ser Ala Met Val 
65                  70                  75              


<210>  163
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  163

Met Gln Ile Phe Val Lys Thr His Thr Ala Lys Thr Ile Leu Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Asn Leu Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Phe Arg Phe Arg Gly Asn Thr Leu 
65                  70                  75              


<210>  164
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  164

Met Gln Ile Phe Val Lys Thr Pro Thr Gly Met Ser Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Val 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Phe Lys Leu Trp Arg Arg Ser Met 
65                  70                  75              


<210>  165
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  165

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Glu 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Ser Trp Asp Phe Lys 
65                  70                  75              


<210>  166
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  166

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys His 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Ser Arg Leu Lys 
65                  70                  75              


<210>  167
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  167

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Val Lys Asn 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Ile His Gly Ser Gln Lys 
65                  70                  75              


<210>  168
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  168

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile His Lys Gln 
    50                  55                  60                  


Ser Thr Leu Phe Leu Val Leu Arg Leu Arg Gly Leu Ser Ser 
65                  70                  75              


<210>  169
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Ubiquitin variant USP21-

<400>  169

Met Gln Ile Phe Val Lys Thr Leu Thr Gly Lys Thr Ile Thr Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Arg Leu Ile Phe Ala Gly Lys 
        35                  40                  45              


Gln Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Gln Lys Asp 
    50                  55                  60                  


Ser Thr Leu Phe Leu Leu Leu Arg Leu Arg Gly Leu Gln Tyr 
65                  70                  75              


<210>  170
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  UIM1

<400>  170

Gly Gly Gly Gly Ala Ala Asp Glu Glu Glu Leu Ile Arg Lys Ala Ile 
1               5                   10                  15      


Glu Leu Ser Leu Lys Glu Ser Arg Asn Ser Gly Gly Tyr 
            20                  25                  


<210>  171
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  UIM1a

<400>  171

Gly Gly Gly Gly Ala Ala Asp Glu Glu Glu Leu Ile Arg Lys Ala Ile 
1               5                   10                  15      


Glu Leu Ala Leu Lys Glu Ser Arg Asn Ser Gly Gly Tyr 
            20                  25                  


<210>  172
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  UIM1b

<400>  172

Gly Gly Gly Gly Ala Ala Asp Glu Glu Glu Leu Ile Arg Lys Leu Ile 
1               5                   10                  15      


Glu Leu Ser Leu Lys Glu Ser Arg Asn Ser Gly Gly Tyr 
            20                  25                  


<210>  173
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Arg, Tyr, Asp, His, Glu, Pro, Leu, Thr, or Lys

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Val, Asp, Met, Tyr, Ser, Ile or Leu

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Asn, Met, Iso, Gln, His, Arg, Glu, Thr, Pro, Val, Gly, Leu
       or Tyr

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Phe, Gly, Ile, Arg, Pro, Met, His, Val or Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Met, Trp, Ser, Ala, Leu, Val, Ile, Tyr, Asn, Arg, Lys or 
       Pro

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Thr, Ala, Leu, Met, Arg, Gln, Trp, Val, His or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Arg, Thr, Asn, Glu, Trp, Phe, Asp, Met, Tyr, Gly, Gln, 
       His, Leu, Ser or Ala

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Ile, His, Ala, Asn, Ser, Met, Val, Gly, Arg, Asp or Phe

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is Ile, Tyr, Asn, Arg, Phe, Pro, Gln, Ala, Met, His, Ser, 
       Gly, Asp, Glu or Leu

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Xaa is Gln

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  Xaa is Asp

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  Xaa is Thr, Ser, Lys, Phe, Ile, Tyr, Asn or Gly

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  Xaa is Val, Phe, Thr, Asn, Leu, Ser or Tyr

<220>
<221>  MISC_FEATURE
<222>  (46)..(46)
<223>  Xaa is Asp, Val, Thr, Asn, Phe, Gly, Ser or Ile

<220>
<221>  MISC_FEATURE
<222>  (47)..(47)
<223>  Xaa is Thr, Arg, Trp, Phe, Arg, Lys, Ala or Val

<220>
<221>  MISC_FEATURE
<222>  (48)..(48)
<223>  Xaa is Gln, Asn, Thr, Met, Leu, Asp, Arg or Trp

<220>
<221>  MISC_FEATURE
<222>  (49)..(49)
<223>  Xaa is Arg, Leu, Pro, Lys, Thr, Ile, His, Phe or Glu

<220>
<221>  MISC_FEATURE
<222>  (62)..(62)
<223>  Xaa is His, Ser, Leu, Pro, Arg, Gly, Lys, Glu, Asn, Tyr or Val

<220>
<221>  MISC_FEATURE
<222>  (63)..(63)
<223>  Xaa is Asn, Arg, Lys, Pro, Thr, Met, Tyr, Gln, Gly, Trp, His or 
       Leu

<220>
<221>  MISC_FEATURE
<222>  (64)..(64)
<223>  Xaa is His, Val, Ile, Arg, Ser, Trp, Asp, Tyr, Lys, Gln, Phe, 
       Gly, Ala, Thr, Leu or Asn

<220>
<221>  MISC_FEATURE
<222>  (66)..(66)
<223>  Xaa is Ala or Tyr

<220>
<221>  MISC_FEATURE
<222>  (68)..(68)
<223>  Xaa is Tyr, Phe, Ala, Arg, Pro, Gly, Lys, Leu, Ser, Gln, Asp or 
       Asn

<220>
<221>  MISC_FEATURE
<222>  (70)..(70)
<223>  Xaa is Leu, Lys, Phe, Trp, Ala, Gly, Met or Ile

<220>
<221>  MISC_FEATURE
<222>  (71)..(71)
<223>  Xaa is Phe, Met, Val, Lys, Gly, Arg, Trp, Ser, Ala, Thr or Ile

<220>
<221>  MISC_FEATURE
<222>  (72)..(72)
<223>  Xaa is Lys, Thr, Ile, Trp, Ser, Met or Gly

<220>
<221>  MISC_FEATURE
<222>  (73)..(73)
<223>  Xaa is Met, Phe, Asp, Ile, Pro, Arg, His or Val

<220>
<221>  MISC_FEATURE
<222>  (74)..(74)
<223>  Xaa is Trp, Leu, Tyr, His, Phe, Ser, Pro, Ile, Gly or Thr

<220>
<221>  MISC_FEATURE
<222>  (75)..(75)
<223>  Xaa is Ser, Arg, Ala, Leu, Val, Thr, Asp, Trp or Phe

<220>
<221>  MISC_FEATURE
<222>  (76)..(76)
<223>  Xaa is His, Glu, Val, Gln, Leu, Cys, Asn, Ala, Trp, Ile, Arg, 
       Tyr, Met, Thr Asp or Lys

<220>
<221>  MISC_FEATURE
<222>  (77)..(77)
<223>  Xaa is Arg, Lys, Ala, Ile, Ser, Asp, Asn, Phe, Glu, Trp, Gln, 
       His, Leu, Val, Tyr, Thr or Met

<220>
<221>  MISC_FEATURE
<222>  (78)..(78)
<223>  Xaa is Arg, Thr, Ala, Gln, His, Lys, Met, Val, Leu, Ile, Phe, 
       Cys, Glu, Tyr, Ser, Asn or Pro

<400>  173

Met Xaa Ile Xaa Val Xaa Thr Xaa Xaa Xaa Xaa Xaa Ile Xaa Leu Glu 
1               5                   10                  15      


Val Glu Pro Ser Asp Thr Ile Glu Asn Val Lys Ala Lys Ile Gln Asp 
            20                  25                  30          


Lys Glu Gly Ile Pro Pro Asp Gln Gln Xaa Leu Xaa Phe Xaa Xaa Xaa 
        35                  40                  45              


Xaa Leu Glu Asp Gly Arg Thr Leu Ser Asp Tyr Asn Ile Xaa Xaa Xaa 
    50                  55                  60                  


Ser Xaa Leu Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
65                  70                  75              


